United BioSource (UBC) Acquires Evidinno Outcomes Research
January 5, 2026
United BioSource LLC (UBC) acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and health economics/HEOR. The acquisition will expand UBC’s evidence generation and late-stage/post-approval capabilities, with Evidinno operating as a wholly owned subsidiary.
- Buyers
- United BioSource LLC (UBC)
- Targets
- Evidinno Outcomes Research Inc. (Evidinno)
- Industry
- Healthcare Services
- Location
- British Columbia, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Buenavista Equity Partners (via Evidenze) Acquires Chrestos Concept GmbH & Co. KG
November 22, 2024
Healthcare Services
Buenavista Equity Partners has acquired German CRO Chrestos Concept GmbH & Co. KG through its healthcare platform Evidenze Group Europe. The add-on expands Evidenze's capabilities in clinical trial design, biostatistics and data science and strengthens its presence in Germany as part of a buy-and-build strategy.
-
iuvo BioScience Acquires Promedica International
January 18, 2024
Healthcare Services
iuvo BioScience, a Rochester-based specialty preclinical and clinical services provider backed by Ampersand Capital Partners, has acquired Promedica International, an ophthalmology-focused clinical CRO headquartered in Costa Mesa, California. The deal combines iuvo's laboratory and consulting capabilities with Promedica's ophthalmic clinical trial expertise to create an integrated end-to-end ophthalmology clinical research offering.
-
United BioSource (UBC) Acquires Examoto, LLC
July 28, 2022
Healthcare Services
United BioSource (UBC) has acquired Examoto, LLC, a provider of FDA-mandated REMS compliance platforms and risk-mitigation technology for the pharmaceutical industry. The acquisition expands UBC's REMS capabilities by combining Examoto's technology-driven REMS platform with UBC's scientific, safety, and commercialization services; terms were not disclosed.
-
Target RWE Acquires NoviSci Inc.
January 15, 2021
Healthcare Services
Target RWE, a Durham-based real-world evidence solutions company, has acquired NoviSci, Inc., a software analytics and services firm that applies epidemiologic methods and causal inference to health data. Amgen Inc. also made a strategic investment in the combined company, joining existing investors Norwest Venture Partners and 22C Capital to support growth; financial terms were not disclosed.
-
EVERSANA Acquires Cornerstone Research Group
October 30, 2019
Healthcare Services
EVERSANA has agreed to acquire Canada-based Cornerstone Research Group, a health economics and outcomes research (HEOR) firm headquartered in Burlington, Ontario. The acquisition adds HEOR, economic modeling, evidence synthesis and market access capabilities to EVERSANA’s integrated commercial services platform to better support pharmaceutical and medical device clients globally.
-
Evidera (PPD) Acquires Medimix International
May 30, 2019
Data & Analytics
Evidera, a business unit of Pharmaceutical Product Development (PPD), has agreed to acquire Medimix International to expand its real-world evidence (RWE) technology and data capabilities. The deal brings Medimix's LiveTracker cloud platform and access to a panel of ~2.2 million clinicians into Evidera's offerings to better support pharmaceutical, diagnostic and medical device clients.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.